Capital World Investors Amgen Inc Transaction History

Capital World Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $16.5 Million - $20.2 Million	-83,298 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $93.1 Million - $123 Million	-510,831 Reduced 85.98%	83,298 $16.9 Million
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $33,300 - $42,803	176 Added 0.03%	594,129 $143 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1,566 - $1,877	9 Added 0.0%	593,953 $115 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $114 Million - $134 Million	-684,937 Reduced 53.56%	593,944 $109 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $592 Million - $691 Million	-3,318,062 Reduced 72.18%	1,278,881 $249 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $852 Million - $960 Million	4,596,943 New	4,596,943 $953 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.